These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16164104)

  • 1. Pap tests and HPV infection. Advances in screening and interpretation.
    Buechler EJ
    Postgrad Med; 2005 Aug; 118(2):37-40, 43-6. PubMed ID: 16164104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States.
    Irwin K; Montaño D; Kasprzyk D; Carlin L; Freeman C; Barnes R; Jain N; Christian J; Wolters C
    Obstet Gynecol; 2006 Aug; 108(2):397-409. PubMed ID: 16880312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HPV test replaces Pap test in Uppsala].
    Olovsson M; Aarnio R; Rezapour M; Segeblad B; Sjöö EL; Wilander E
    Lakartidningen; 2013 Mar 26-Apr 9; 110(13-14):695-6. PubMed ID: 23634626
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus testing in cervical cancer screening.
    Castle PE; Cremer M
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):377-90. PubMed ID: 23732037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for application of molecular tests identyfying HR HPV DNA in the prevention of cervical cancer. Statement of experts from PGS (PTG) and NCLD (KIDL)].
    ;
    Ginekol Pol; 2013 May; 84(5):395-9. PubMed ID: 23819408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward objective cervical cancer screening: maybe the eyes do have it.
    Stoler MH
    Am J Clin Pathol; 2010 Jul; 134(1):5-6. PubMed ID: 20551259
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of the Pap: where is cervical cancer screening headed?
    Ruhl C
    Nurs Womens Health; 2008 Oct; 12(5):427-31. PubMed ID: 18837722
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical screening and human papillomavirus.
    Sheary B; Dayan L
    Aust Fam Physician; 2005 Jul; 34(7):578-80. PubMed ID: 15999169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cytology screening in teens.
    Moscicki AB
    Curr Womens Health Rep; 2003 Dec; 3(6):433-7. PubMed ID: 14613663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
    Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
    Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.
    Westre B; Giske A; Guttormsen H; Wergeland Sørbye S; Skjeldestad FE
    PLoS One; 2019; 14(11):e0221546. PubMed ID: 31689301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil.
    Levi JE; Martins TR; Longatto-Filho A; Cohen DD; Cury L; Fuza LM; Villa LL; Eluf-Neto J
    Cancer Prev Res (Phila); 2019 Aug; 12(8):539-546. PubMed ID: 31189569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
    Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Howard M; Roth P; Lorincz AT; Gafni A; Walter SD
    Arch Pathol Lab Med; 2003 Sep; 127(9):1169-75. PubMed ID: 12946228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of persistent high-risk human papillomavirus infections in Korean women.
    Bae J; Seo SS; Park YS; Dong SM; Kang S; Myung SK; Park SY
    Gynecol Oncol; 2009 Oct; 115(1):75-80. PubMed ID: 19619893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.